Clinical Trial Update: Good Rate of Clinical Response to Cholinesterase Inhibitors in Alzheimer's Disease After Three Months of Treatment

View source ↗

Summary

A clinical trial update reports a favorable rate of clinical response to cholinesterase inhibitors in Alzheimer's disease after three months of treatment. The s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: Federal University of Minas Gerais | Conditions: Late Onset Alzheimer | Status: COMPLETED | Results posted: 2018-06-12